Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-25-043005
Filing Date
2025-05-14
Accepted
2025-05-14 09:22:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5245
  Complete submission text file 0001213900-25-043005.txt   7260
Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111 (800) 304-9888
GT Biopharma, Inc. (Subject) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-32837 | Film No.: 25943050
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 510 MADISON AVENUE SUITE 1400 NEW YORK NY 10022
Business Address 510 MADISON AVENUE SUITE 1400 NEW YORK NY 10022 212-586-8224
Five Narrow Lane LP (Filed by) CIK: 0001927401 (see all company filings)

EIN.: 870848402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G